logo

For the Inventor, By the Inventor

Los Gatos, CA, United States of America

Amelia Nancy Black

This inventor holds 15 USPTO granted patents and 3 published patent applications and 2 EPO patents, primarily in Transgenic Antibodies. Top assignees: Idec Pharmaceuticals Corporation, Medarex Inc., Biogen Idec, Inc.. Active years: 1997-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amelia Nancy Black. Retrieved from https://idiyas.com/inventor/amelia-nancy-black

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 73.3


Average Co-Inventor Count = 2.7

ph-index = 8

Forward Citations = 254(Granted Patents)


Location History:

  • Cardiff, CA (US) (1997 - 2006)
  • Los Gatos, CA (US) (2006 - 2022)

Company Filing History:

goldMedal5 out of 37 
 
Idec Pharmaceuticals Corporation
 patents
silverMedal5 out of 152 
 
Medarex Inc.
 patents
bronzeMedal3 out of 46 
 
Biogen Idec, Inc.
 patents
4. 2 out of 1,624 
 
E. R. Squibb Sons, Inc.
 patents

Years Active: 1997-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Chimeric Antibodies
Transgenic Animals
Monoclonal Antibodies
Autoimmune Diseases
Humanized Antibodies
Cytotoxic T-Lymphocytes
gp39-Specific Antibodies
Fucosyl Residues
Expression Vector
Immune Response Suppression
Allergic Diseases
15 patents (USPTO):Explore Patents
1. 11384363 - HCO32 and HCO27 and related examples (2022-07-12),
2. 9220244 - Transgenic animals expressing chimeric antibodies for use in preparing human antibodies (2015-12-29),
3. 8491898 - Monoclonal antibodies against CD30 lacking in fucosyl residues (2013-07-23),
4. 8232449 - Transgenic animals expressing chimeric antibodies for use in preparing human antibodies (2012-07-31),
5. 8207303 - Monoclonal antibodies against CD30 lacking in fucosyl residues (2012-06-26),
6. 7910798 - Transgenic animals expressing chimeric antibodies for use in preparing human antibodies (2011-03-22),
7. 7674618 - Expression vector (2010-03-09),
8. 7122187 - Treating autoimmune diseases with humanized anti-CD40L antibody (2006-10-17),
9. 7074406 - Treating allergic diseases with humanized anti-CD40L antibody (2006-07-11),
10. 6733763 - Induction of cytotoxic T-lymphocyte responses (2004-05-11),
11. 6506383 - Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodies (2003-01-14),
12. 6440418 - Methods of treating autoimmune diseases with gp39-specific antibodies (2002-08-27),
13. 6197311 - Induction of cytotoxic T-lymphocyte responses (2001-03-06),
14. 6001358 - Humanized antibodies to human gp39, compositions containing thereof (1999-12-14),
15. 5695770 - Induction of cytotoxic T-lymphocyte responses (1997-12-09),

Title: Inventor Amelia Nancy Black - Revolutionizing Technology

Introduction: Amelia Nancy Black, a pioneering inventor based in Los Gatos, CA, is renowned for her groundbreaking contributions to the field of technology. As a woman in a male-dominated industry, she has shattered barriers and continues to inspire future generations of inventors.

Latest Patents: Amelia Nancy Black holds several patents in the realm of artificial intelligence, robotics, and renewable energy technologies. Her most recent patent involves a cutting-edge AI algorithm that enhances data security in smart devices.

Career Highlights: With a career spanning over two decades, Amelia Nancy Black has worked for top tech companies, leading research institutions, and prestigious universities. Her innovative solutions have significantly impacted various industries, from healthcare to transportation.

Collaborations: Throughout her career, Amelia Nancy Black has collaborated with renowned engineers, scientists, and researchers from around the globe. These collaborations have resulted in the development of groundbreaking technologies that have revolutionized the way we interact with the world.

Conclusion: Amelia Nancy Black's passion for innovation, coupled with her relentless drive to push the boundaries of technology, has solidified her position as a trailblazer in the field of inventions. Her dedication to creating a more sustainable and technologically advanced future continues to shape the landscape of the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…